Owners, management and financials
CVR: 26123925
Secondary names: NORDIC VALUE ADVISORS ApS, NB CAPITAL ApS
Previous names: NORDIC BIOTECH ApS, NEXGEN BIOTECH ApS
DKK 3,273,154
Gross profit
Net result: DKK 360,368
TECH GROWTH INVEST ApS (33,33-49,99%), C. HANSEN INVEST ApS (25-33,32%)
1 more
CVR · view owners
Florian Schønharting
Board: 2 members
CVR · view management
Active
Founded 29 June 2001
CVR · view overview
2 employees
CVR · 2026
Director role ended: Christian Karsten Hansen
CVR · 24/11/2011
View the full event history
NORDIC BIOTECH ADVISORS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is registered under the industry Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. The company was previously named NEXGEN BIOTECH ApS and NORDIC BIOTECH ApS. The management consists of Florian Schønharting. The board consists of Florian Schønharting and Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. Equity in the 2025 report amounted to DKK 4,622,219.
Source: annual report 2025, Danish Business Authority
The financial health of NORDIC BIOTECH ADVISORS ApS appears stable, with a notable recovery in profitability in 2025, reporting a profit of 360,368 DKK after a loss in 2024. Gross profit has shown a generally positive trend, increasing from 3,700,141 DKK in 2021 to 4,495,918 DKK in 2023, before slightly declining to 3,273,154 DKK in 2025. The company's equity has consistently grown, reaching 4,622,219 DKK in 2025, indicating a solid financial foundation. However, the absence of disclosed revenue raises concerns about transparency and overall market position within the financial services sector.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at virke som finansierings- og investeringsvirksomhed samt anden i forbindelse hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.3 mio. | 360 t. | 5.4 mio. | 4.6 mio. | 2 | |
| 202401/01/2024 – 31/12/2024 | 1.9 mio. | -573 t. | 5.3 mio. | 4.3 mio. | 2 | |
| 202301/01/2023 – 31/12/2023 | 4.5 mio. | 1.4 mio. | 5.3 mio. | 4.8 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | 3.8 mio. | 943 t. | 4.3 mio. | 3.4 mio. | 2 | |
| 202101/01/2021 – 31/12/2021 | 3.7 mio. | 657 t. | 3.2 mio. | 2.5 mio. | 2 | |
| 202001/01/2020 – 31/12/2020 | 2.7 mio. | -301 t. | 2.5 mio. | 1.8 mio. | 2 | |
| 201901/01/2019 – 31/12/2019 | 3.3 mio. | 81 t. | 3 mio. | 2.1 mio. | 2 | |
| 201801/01/2018 – 31/12/2018 | 3.4 mio. | -119 t. | 2.5 mio. | 2 mio. | 1 | |
| 201701/01/2017 – 31/12/2017 | 3.1 mio. | 86 t. | 2.7 mio. | 2.1 mio. | - | |
| 201601/01/2016 – 31/12/2016 | 3.7 mio. | 569 t. | 2.8 mio. | 2.1 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 3.6 mio. | 274 t. | 2.1 mio. | 1.5 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 2.8 mio. | -162 t. | 1.9 mio. | 1.2 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 3.6 mio. | 9 t. | 2.1 mio. | 1.4 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 3.8 mio. | -63 t. | 2 mio. | 1.4 mio. | 2 |
Compared to 347 companies in Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of NORDIC BIOTECH ADVISORS ApS is 26123925.
NORDIC BIOTECH ADVISORS ApS is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP.
The management of NORDIC BIOTECH ADVISORS ApS consists of Florian Schønharting.
The board of NORDIC BIOTECH ADVISORS ApS consists of Florian Schønharting and Jakob Mosegaard Larsen.
In 2025, NORDIC BIOTECH ADVISORS ApS reported a gross profit of DKK 3,273,154.
NORDIC BIOTECH ADVISORS ApS had 2 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2025. Gross profit came to DKK 3,273,154, and the net result was DKK 360,368.
As of June 30, 2026, Matthew Daniel Perry has left the board of directors of NORDIC BIOTECH ADVISORS ApS.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2024. Gross profit came to DKK 1,874,965, and the net result was DKK -572,578.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2023. Gross profit came to DKK 4,495,918, and the net result was DKK 1,432,611.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2022. Gross profit came to DKK 3,812,316, and the net result was DKK 942,698.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2021. Gross profit came to DKK 3,700,141, and the net result was DKK 657,338.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2020. Gross profit came to DKK 2,730,002, and the net result was DKK -301,432.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2019. Gross profit came to DKK 3,299,583, and the net result was DKK 80,845.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2018. Gross profit came to DKK 3,368,918, and the net result was DKK -119,384.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2017. Gross profit came to DKK 3,148,911, and the net result was DKK 85,668.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2016. Gross profit came to DKK 3,717,818, and the net result was DKK 569,324.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2015. Gross profit came to DKK 3,618,211, and the net result was DKK 273,702.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2014. Gross profit came to DKK 2,807,599, and the net result was DKK -161,863.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2013. Gross profit came to DKK 3,550,848, and the net result was DKK 9,437.
As of June 20, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOTECH ADVISORS ApS.
As of June 20, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH ADVISORS ApS.
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2012. Gross profit came to DKK 3,783,719, and the net result was DKK -62,812.
As of December 5, 2011, Jakob Mosegaard Larsen has joined the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of November 24, 2011, Christian Karsten Hansen has left the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of November 24, 2011, Christian Karsten Hansen has stepped down as director of NORDIC BIOTECH ADVISORS ApS.
As of May 3, 2011, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH ADVISORS ApS.
As of May 3, 2011, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH ADVISORS ApS.
As of April 29, 2011, Jennifer Louise Prender has stepped down as økonomidirektør of NORDIC BIOTECH ADVISORS ApS.
As of October 29, 2010, Florian Schønharting is registered as adm. dir. of NORDIC BIOTECH ADVISORS ApS.
As of October 8, 2008, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH ADVISORS ApS.
As of October 8, 2008, Benny Lynge Sørensen has stepped down as auditor of NORDIC BIOTECH ADVISORS ApS.
As of May 16, 2008, Cora Louise Madsen has stepped down as økonomidirektør of NORDIC BIOTECH ADVISORS ApS.
As of March 1, 2008, Jennifer Louise Prender is registered as økonomidirektør of NORDIC BIOTECH ADVISORS ApS.
As of December 31, 2003, Lars Henrik Munch has left the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of December 31, 2003, Erik Hoffmeyer has left the board of directors of NORDIC BIOTECH ADVISORS ApS.
On February 27, 2002, the company changed its name from NEXGEN BIOTECH ApS to NORDIC BIOTECH ADVISORS ApS.
As of January 21, 2002, Matthew Daniel Perry has joined the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of September 28, 2001, TECH GROWTH INVEST ApS is registered as an owner of NORDIC BIOTECH ADVISORS ApS with an ownership share of 33%.
As of September 28, 2001, is registered as an owner of NORDIC BIOTECH ADVISORS ApS with an ownership share of 25%.
As of August 28, 2001, C. HANSEN INVEST ApS is registered as an owner of NORDIC BIOTECH ADVISORS ApS with an ownership share of 25%.
On July 16, 2001, the company changed its name from NORDIC BIOTECH ApS to NEXGEN BIOTECH ApS.
As of June 29, 2001, Benny Lynge Sørensen has been appointed auditor of NORDIC BIOTECH ADVISORS ApS.
As of June 29, 2001, Christian Karsten Hansen has joined the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of June 29, 2001, Lars Henrik Munch has joined the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of June 29, 2001, Erik Hoffmeyer has joined the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of June 29, 2001, Florian Schønharting has joined the board of directors of NORDIC BIOTECH ADVISORS ApS.
As of June 29, 2001, Christian Karsten Hansen is registered as director of NORDIC BIOTECH ADVISORS ApS.
As of June 29, 2001, Cora Louise Madsen is registered as økonomidirektør of NORDIC BIOTECH ADVISORS ApS.
NORDIC BIOTECH ADVISORS ApS was founded on June 29, 2001.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 43001655
CVR 46560981
CVR 40360662
CVR 29216487
CVR 33069685
